{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:46:04Z","timestamp":1789782364020,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1124\/dmd.113.055400","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T03:13:24Z","timestamp":1386126804000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4\/5 in the Dihydropyridine Dehydrogenation"],"prefix":"10.1016","volume":"42","author":[{"given":"Yanlin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.055400_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00005344-199117001-00003","article-title":"Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist","volume":"17","author":"Abernethy","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.113.055400_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/00498258809041653","article-title":"Metabolism of amlodipine in the rat and the dog: a species difference","volume":"18","author":"Beresford","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.055400_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00498258809041660","article-title":"Metabolism and kinetics of amlodipine in man","volume":"18","author":"Beresford","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.055400_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000258688","article-title":"CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease","volume":"31","author":"Bhatnagar","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1124\/dmd.113.055400_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00498254.2010.523734","article-title":"CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity","volume":"41","author":"Christensen","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.055400_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2125.1986.tb02874.x","article-title":"The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily","volume":"22","author":"Faulkner","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.113.055400_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clpt.2005.04.005","article-title":"Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers","volume":"78","author":"Glesby","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.055400_bib8","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/jm00110a012","article-title":"Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4","volume":"34","author":"Guengerich","year":"1991","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.113.055400_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clinthera.2010.01.017","volume":"32","author":"Kim","year":"2010","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.113.055400_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clpt.2006.09.009","article-title":"Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects","volume":"80","author":"Kim","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.055400_bib11","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00653-11","article-title":"Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.113.055400_bib12","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1124\/dmd.112.046144","article-title":"Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5","volume":"40","author":"Li","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055400_bib13","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00005344-198812007-00012","article-title":"The metabolism and pharmacokinetics of amlodipine in humans and animals","volume":"12","author":"Stopher","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.113.055400_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2007.10.003","article-title":"Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry","volume":"33","author":"Suchanova","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.113.055400_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.aca.2006.05.065","article-title":"Liquid chromatography-tandem mass spectrometry in chiral study of amlodipine biotransformation in rat hepatocytes","volume":"573-574","author":"Suchanova","year":"2006","journal-title":"Anal Chim Acta"},{"key":"10.1124\/dmd.113.055400_bib16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1124\/dmd.112.045302","article-title":"Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs","volume":"40","author":"Walsky","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055400_bib17","doi-asserted-by":"crossref","unstructured":"Zhang YP, Zuo XC, Huang ZJ, Cai JJ, Wen J, Duan DD and Yuan H CYP3A5 polymorphism, amlodipine and hypertension. J Hum Hypertens 2013 DOI: 10.1038\/jhh.2013.67 [Epub ahead of print]","DOI":"10.1038\/jhh.2013.67"},{"key":"10.1124\/dmd.113.055400_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2133\/dmpk.DMPK-12-RG-148","article-title":"Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine","volume":"28","author":"Zuo","year":"2013","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.055400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:11:56Z","timestamp":1739905916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624098271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0090955624098271"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.055400","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4\/5 in the Dihydropyridine Dehydrogenation","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.055400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}